Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03432884
Brief Title: A Two-Part Phase 1 Study to Investigate the Safety and Tolerability of Supratherapeutic Dose of Zanubrutinib and Effect of Zanubrutinib on Cardiac Repolarization in Healthy Subjects

First Submitted : January 19, 2018
First Submitted that Met QC Criteria : February 13, 2018
First Posted : February 14, 2018

Last Update Submitted that Met QC Criteria : May 24, 2018
Last Update Posted : May 25, 2018